ArticleScientific reports2018

A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.

Jesus Campagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.